These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25914107)

  • 1. Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review.
    Heringa SM; Begemann MJ; Goverde AJ; Sommer IE
    Schizophr Res; 2015 Nov; 168(3):603-13. PubMed ID: 25914107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen augmentation in schizophrenia: a quantitative review of current evidence.
    Begemann MJ; Dekker CF; van Lunenburg M; Sommer IE
    Schizophr Res; 2012 Nov; 141(2-3):179-84. PubMed ID: 22998932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.
    Huerta-Ramos E; Iniesta R; Ochoa S; Cobo J; Miquel E; Roca M; Serrano-Blanco A; Teba F; Usall J
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):223-31. PubMed ID: 24342775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta-analysis.
    Dauwan M; Begemann MJ; Heringa SM; Sommer IE
    Schizophr Bull; 2016 May; 42(3):588-99. PubMed ID: 26547223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies.
    Fusar-Poli P; Berger G
    J Clin Psychopharmacol; 2012 Apr; 32(2):179-85. PubMed ID: 22367656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis.
    de Boer J; Prikken M; Lei WU; Begemann M; Sommer I
    NPJ Schizophr; 2018 Jan; 4(1):1. PubMed ID: 29321530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: an 8-week, double-blind, randomized add-on two-center trial.
    Ritsner MS; Bawakny H; Kreinin A
    Psychiatry Clin Neurosci; 2014 Jun; 68(6):432-40. PubMed ID: 24548129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.
    Usall J; Huerta-Ramos E; Iniesta R; Cobo J; Araya S; Roca M; Serrano-Blanco A; Teba F; Ochoa S
    J Clin Psychiatry; 2011 Nov; 72(11):1552-7. PubMed ID: 21903021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oxytocin and genetic variants on brain and behaviour: Implications for treatment in schizophrenia.
    Bartholomeusz CF; Ganella EP; Labuschagne I; Bousman C; Pantelis C
    Schizophr Res; 2015 Nov; 168(3):614-27. PubMed ID: 26123171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of selective estrogen receptor modulators in the treatment of schizophrenia.
    Bratek A; Krysta K; Drzyzga K; Barańska J; Kucia K
    Psychiatr Danub; 2016 Sep; 28(Suppl-1):45-48. PubMed ID: 27663804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia.
    Rubin LH; Carter CS; Drogos LL; Pournajafi-Nazarloo H; Sweeney JA; Maki PM
    Schizophr Res; 2015 Aug; 166(1-3):269-75. PubMed ID: 25990704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials.
    Oya K; Matsuda Y; Matsunaga S; Kishi T; Iwata N
    Eur Arch Psychiatry Clin Neurosci; 2016 Aug; 266(5):439-50. PubMed ID: 26303414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of sex hormones to gender differences in schizophrenia: A review.
    da Silva TL; Ravindran AV
    Asian J Psychiatr; 2015 Dec; 18():2-14. PubMed ID: 26321672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do we need oxytocin to treat schizophrenia? A randomized clinical trial.
    Dagani J; Sisti D; Abelli M; Di Paolo L; Pini S; Raimondi S; Rocchi MB; Saviotti FM; Scocco P; Totaro S; Balestrieri M; de Girolamo G
    Schizophr Res; 2016 Apr; 172(1-3):158-64. PubMed ID: 26883950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regression.
    Velthorst E; Koeter M; van der Gaag M; Nieman DH; Fett AK; Smit F; Staring AB; Meijer C; de Haan L
    Psychol Med; 2015 Feb; 45(3):453-65. PubMed ID: 24993642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis.
    Sommer IE; de Witte L; Begemann M; Kahn RS
    J Clin Psychiatry; 2012 Apr; 73(4):414-9. PubMed ID: 22225599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia.
    Guastella AJ; Ward PB; Hickie IB; Shahrestani S; Hodge MA; Scott EM; Langdon R
    Schizophr Res; 2015 Nov; 168(3):628-33. PubMed ID: 26150070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Li Z; Wang Y; Wang Z; Kong L; Liu L; Li L; Tang Y
    Acta Psychiatr Scand; 2023 Apr; 147(4):360-372. PubMed ID: 36585771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.